breast tissues; adjacent normal tissues
MCF-7
-
not specified
RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
Diagnostic potential for discriminating breast cancer from normal tissues and distinguishing disease stages/progression.
circMTO1 is down-regulated in breast cancer tissues compared with adjacent normal tissues and can be quantified by the proposed CRISPR nanoswitch. Its measurement contributes to diagnostic discrimination and staging/progression classification (especially when combined with circCDYL).
0.559
Mirror-synchronized asymmetric CRISPR nanoswitch for single-molecule profiling of multiple circRNAs in different stages of breast cancer.
combined biological and clinical study